A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies

Published:2021-03 Issue:3 Volume:7 Page:e06438
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Nielsen Tyler J.^ORCID,Ring Brian Z.^ORCID,Seitz Robert S.^ORCID,Hout David R.^ORCID,Schweitzer Brock L.^ORCID

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference33 articles.

1. Comprehensive analysis of the clinical immuno-oncology landscape;Tang;Ann. Oncol.,2018

2. Review of indications of FDA-approved immune checkpoint inhibitors per NCCN guidelines with the level of evidence;Vaddepally;Cancers,2020

3. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy;Havel;Nat. Rev. Canc.,2019

4. Immuno-oncology: emerging targets and combination therapies;Marshall;Front. Oncol.,2018

5. Immune-related adverse events associated with immune checkpoint blockade;Postow;N. Engl. J. Med.,2018

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis;Frontiers in Immunology;2024-08-01

2. Pharmacological Mechanism of Mume Fructus in the Treatment of Triple-Negative Breast Cancer Based on Network Pharmacology;Applied Biochemistry and Biotechnology;2024-04-26

3. Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial);Journal for ImmunoTherapy of Cancer;2023-09

4. A phase Ib trial of pembrolizumab plus paclitaxel or flat-dose capecitabine in 1st/2nd line metastatic triple-negative breast cancer;npj Breast Cancer;2023-06-21

5. Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer;The Breast;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3